Matthew J. Seamon, JD (Esq), PharmD - College of Pharmacy
Matthew J. Seamon, JD (Esq), PharmD - College of Pharmacy
Matthew J. Seamon, JD (Esq), PharmD - College of Pharmacy
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Matthew</strong> J. <strong>Seamon</strong>, <strong>JD</strong>, <strong>PharmD</strong><br />
Page 6 <strong>of</strong> 15<br />
Publications<br />
2013 Rizo M, <strong>Seamon</strong> M. Pharmacist’s liability. What my pharmacy law<br />
pr<strong>of</strong>essor did not cover. IJPC 2013;17(4):290-293.<br />
2011 <strong>Seamon</strong>, MJ. Managing Medical Marijuana in the Health-System<br />
<strong>Pharmacy</strong>. <strong>Pharmacy</strong> Purchasing & Products. 2011;8(11):10-7<br />
2010 <strong>Seamon</strong> MJ. Antitrust and the Biopharmaceutical Industry: Lessons from<br />
Hatch-Waxman and an Early Evaluation <strong>of</strong> the Biologics Price<br />
Competition and Innovation Act <strong>of</strong> 2009. Nova Law Review, 2010;34:629-<br />
78.<br />
2010 Clauson KA, <strong>Seamon</strong> MJ, Fox BI. Pharmacist’s Duty to Warn in the Age <strong>of</strong><br />
Social Media. Am J Health-Syst Pharm 2010;67:1290-3.<br />
2010 <strong>Seamon</strong>, MJ. Medical Marijuana, an Evolving Landscape. Medscape<br />
Pharmacists, available @ http://www.medscape.com/viewarticle/716940.<br />
2008 Clauson KA, Fass J, <strong>Seamon</strong> MJ. Legal Requirements for Drug Information<br />
Resources Maintained by Pharmacies. Drug Info Journal 2008;42:569-82<br />
2008 Fass J, <strong>Seamon</strong> MJ. Evaluation <strong>of</strong> state schedule II controlled substance<br />
laws. J Pharm Technol 2008;24:77-81<br />
2008 Fass J, <strong>Seamon</strong> MJ. Multiple Schedule II Rxs: Road to disaster Drug<br />
Topics 2008; Jan 28: 32. [Viewpoint]<br />
2007 Fass J, <strong>Seamon</strong> MJ, Cytaki J. Rx Package Inserts: Redesigned. J Fam Pract<br />
2007;56:438-441.<br />
2007 <strong>Seamon</strong> MJ, Fass J, Maniscalco-Feichtl M, Abu-Shraie N. Medical Marijuana<br />
and the Developing Role <strong>of</strong> the Pharmacist. Am J Health-Syst Pharm<br />
2007;64:1037-44.<br />
2007 Clauson KA, Polen H, Marsh WA, <strong>Seamon</strong> MJ, Ortiz BO. Clinical Decision<br />
Support Tools: Analysis <strong>of</strong> Commercially Available Online Drug<br />
Information Databases. BMC Med Inform Decis Mak. 2007 Mar 8;7(1):7.<br />
2007 <strong>Seamon</strong> MJ. Book Review. Medication Errors, 2 nd Edition. Edited by<br />
Michael R. Cohen, Published by the American Pharmacists Association. Ann<br />
Pharmacother 2007;41:722-3.<br />
2006 <strong>Seamon</strong> MJ. The Law on Medical Marijuana. Ann Pharmacother<br />
2006;40:2211-5. [Honored to appear on Medscape in full text]<br />
2006 Fass J, <strong>Seamon</strong> MJ, <strong>Seamon</strong> E. Plan B Nonprescription Use. Practical<br />
Implications for the Pharmacist. <strong>Pharmacy</strong> Times 2006;10:18-24.<br />
2006 Cubbedu LX, <strong>Seamon</strong> MJ. Statin Withdrawal: Clinical Implications and<br />
Molecular Mechanisms. Pharmacotherapy 2006;1288-96.<br />
2006 <strong>Seamon</strong> MJ. Plan B for the FDA: A Need for a Third Class <strong>of</strong> Drug<br />
Regulation in the United States Involving a ‘Pharmacist-Only’ Class <strong>of</strong><br />
Drugs. William Mary J Women Law, 2006;12(3):521-62. [Lead Article]
Change language